佳學(xué)基因遺傳病基因檢測機(jī)構(gòu)排名,三甲醫(yī)院的選擇

基因檢測就找佳學(xué)基因!

熱門搜索
  • 癲癇
  • 精神分裂癥
  • 魚鱗病
  • 白癜風(fēng)
  • 唇腭裂
  • 多指并指
  • 特發(fā)性震顫
  • 白化病
  • 色素失禁癥
  • 狐臭
  • 斜視
  • 視網(wǎng)膜色素變性
  • 脊髓小腦萎縮
  • 軟骨發(fā)育不全
  • 血友病

客服電話

4001601189

在線咨詢

CONSULTATION

一鍵分享

CLICK SHARING

返回頂部

BACK TO TOP

分享基因科技,實現(xiàn)人人健康!
久久99精品久久久久婷婷,亚洲网曝门精品,老子影院午夜伦手机不卡无
http://npz842.cn/tk/jiema/liaojie/2024/40765.html
×
查病因,阻遺傳,哪里干?佳學(xué)基因準(zhǔn)確有效服務(wù)好! 靶向用藥怎么搞,佳學(xué)基因測基因,優(yōu)化療效 風(fēng)險基因哪里測,佳學(xué)基因
PrevNext
當(dāng)前位置:????致電4001601189! > 基因課堂 > 基因價值 > 了解基因 >

【佳學(xué)基因檢測】GABRA1疾病風(fēng)險評估的作用

GABRA1基因檢測檢測的是人的基因序列變化及表征數(shù)據(jù)庫中標(biāo)號為2554的核酸分子上的堿基序列。它的突序及序列異常會引起正在通過基因解碼技術(shù)進(jìn)行收集、查證并編輯,請關(guān)注佳學(xué)基因,獲得及時更新的人類基因序列變化與疾病表征數(shù)據(jù)庫的更新內(nèi)容。針對基因信息變化所產(chǎn)生的健康問題的靶向藥物情況勞拉西泮(抑制細(xì)胞外配體門控離子通道活性);乙氯維諾(抑制細(xì)胞外配體門控離子通道活性);恩氟烷(抑制細(xì)胞外配體門控離子通道活性);替馬西泮(抑制細(xì)胞外配體門控離子通道活性);替馬西泮( Inhibitory extracellular ligand-gated ion channel activity);Butabarbital(抑制胞外配體門控離子通道活性);Butalbital(抑制胞外配體門控離子通道活性);Butalbital(抑制胞外配體門控離子通道活性);托吡酯(抑制胞外配體門離子通道活性)配體門控離子通道活性);托吡酯(抑制性細(xì)胞外配體門控離子通道活性);依托咪酯(抑制性細(xì)胞外配體門控離子通道活性);依托咪酯(抑制性細(xì)胞外配體門控離子通道活性);他布妥(抑制性細(xì)胞外配體-門控離子通道活性)門離子

佳學(xué)基因檢測】GABRA1疾病風(fēng)險評估的作用


基因檢測的序列名稱:

GABRA1


人體基因序列變化與疾病表征數(shù)據(jù)庫中的基因代碼:

2554


人體基因序列數(shù)據(jù)庫中國際交流名稱全稱

gamma-aminobutyric acid type A receptor alpha1 subunit


中國數(shù)據(jù)庫中基因全稱:

γ-氨基丁酸A型受體alpha1亞基


基因檢測報告英文版基因簡介

This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]


基因突變所影響的基因信息

該基因編碼γ-氨基丁酸(GABA)受體。GABA是哺乳動物大腦中主要的抑制性神經(jīng)遞質(zhì),在GABA-A受體上起作用,該受體是配體門控的氯離子通道。這些通道的氯化物電導(dǎo)率可以通過與GABA-A受體結(jié)合的試劑(例如苯二氮雜)來調(diào)節(jié)。GABA-A受體是五聚體,由幾種亞基的蛋白質(zhì)組成:α,β,γ,δ和rho。該基因的突變會引起青少年肌陣攣性癲癇和兒童期癲癇型4型。已為該基因鑒定出了編碼同一蛋白的多種轉(zhuǎn)錄物變體。[由RefSeq提供,2008年7月]


國際國內(nèi)該堿基基因序列的其他英語文字母簡稱:

ECA4, EIEE19, EJM, EJM5


基因解碼對該基因序列在細(xì)胞核中的染色體所給予的編號:

該基因序列位于人類第5號染色體上。


基因解碼對基因序列的正確定位

該基因序列在GRCh37版本中的起始位置坐標(biāo)為:161274197;結(jié)束位置坐標(biāo)為:161326965。該基因序列在GRCh38版本中的起始位置坐標(biāo)為:161847191;結(jié)束位置坐標(biāo)為:161899959。正確的基因信息定位是基因檢測和對檢測結(jié)果進(jìn)行正確解讀的關(guān)鍵。


佳學(xué)基因解碼對該基因的功能分類:國際版

Transporters/Transporter channels and pores


基因解碼對該基因的功能分類:中文版

轉(zhuǎn)運體/轉(zhuǎn)運體通道和孔


結(jié)構(gòu)與功能基因解碼所揭示的該基因在細(xì)胞內(nèi)發(fā)揮作用的場所(國際版):

正在通過基因解碼技術(shù)進(jìn)行收集、查證并編輯,請關(guān)注佳學(xué)基因,獲得及時更新的人類基因序列變化與疾病表征數(shù)據(jù)庫的更新內(nèi)容


結(jié)構(gòu)與功能基因解碼所揭示的該基因發(fā)揮作用的細(xì)胞內(nèi)位置(中文版):

正在通過基因解碼技術(shù)進(jìn)行收集、查證并編輯,請關(guān)注佳學(xué)基因,獲得及時更新的人類基因序列變化與疾病表征數(shù)據(jù)庫的更新內(nèi)容


該基因序列變化后增加的疾病風(fēng)險(國際版):

EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; Essential Tremor; Hemiclonic seizures; EPILEPSY, CHILDHOOD ABSENCE, 1; Obtundation status; Infantile Severe Myoclonic Epilepsy; Focal Clonic Seizures; Myoclonic Epilepsy, Juvenile; Epileptic drop attack; Hypotonic seizures; Febrile Convulsions; Ataxia; Hepatic Encephalopathy; Absence Epilepsy; Epileptic encephalopathy; Alcoholic Intoxication; Generalized myoclonic seizures; Epilepsies, Myoclonic; Ovarian Cysts; Alcohol abuse; AMYOTROPHIC LATERAL SCLEROSIS 1; Myoclonic Epilepsies, Progressive; Abnormal behavior; Photosensitivity of skin; Status Epilepticus; Electroencephalogram abnormal; Tremor; Mood Disorders; Cerebellar Ataxia; Autistic Disorder; Alcoholic Intoxication, Chronic; Bipolar Disorder; Muscle hypotonia; Cognitive delay; Global developmental delay; Mental and motor retardation; Dull intelligence; Low intelligence; Mental Retardation; Mental deficiency; Poor school performance; Intellectual Disability; Schizophrenia


如果該基因突變后,風(fēng)險可能增加的疾病類型(中文版):

癲癇特發(fā)性全身性易感性12型;癲癇性腦病早期嬰兒19 型;特發(fā)性震顫;半陣攣發(fā)作;癲癇兒童缺失2型;遲鈍狀態(tài);嬰兒嚴(yán)重肌陣攣性癲癇;局灶性陣攣發(fā)作;肌陣攣性癲癇青少年;癲癇發(fā)作;低滲性癲癇發(fā)作;熱性驚厥;共濟(jì)失調(diào);肝性腦病;失神性癲癇;癲癇性腦病;酒精中毒;全身性肌陣攣發(fā)作;癲癇、肌陣攣;卵巢囊腫;濫用酒精;肌萎縮側(cè)索硬化 2型;肌陣攣性癲癇進(jìn)行性;異常行為;皮膚光敏性;癲癇持續(xù)狀態(tài);腦電圖異常;震顫;情緒障礙;小腦性共濟(jì)失調(diào);自閉癥;酒精中毒慢性;躁郁癥;肌肉張力減退;認(rèn)知延遲;整體發(fā)育遲緩;智力和運動遲緩;智力遲鈍;智力低下;智力低下;精神缺陷;學(xué)習(xí)成績差;智力殘疾;精神分裂癥


GWAS基因檢測所建立的與該基因的疾病關(guān)聯(lián)(國際版):

正在通過基因解碼技術(shù)進(jìn)行收集、查證并編輯,請關(guān)注佳學(xué)基因,獲得及時更新的人類基因序列變化與疾病表征數(shù)據(jù)庫的更新內(nèi)容


GWAS基因檢測所解碼的該基因突變會增加風(fēng)險的疾病種類(中文版):

正在通過基因解碼技術(shù)進(jìn)行收集、查證并編輯,請關(guān)注佳學(xué)基因,獲得及時更新的人類基因序列變化與疾病表征數(shù)據(jù)庫的更新內(nèi)容


以該基因做靶點的藥物(國際版):

Lorazepam (Inhibitory extracellular ligand-gated ion channel activity);Ethchlorvynol (Inhibitory extracellular ligand-gated ion channel activity);Enflurane (Inhibitory extracellular ligand-gated ion channel activity);Temazepam (Inhibitory extracellular ligand-gated ion channel activity);Temazepam (Inhibitory extracellular ligand-gated ion channel activity);Butabarbital (Inhibitory extracellular ligand-gated ion channel activity);Butalbital (Inhibitory extracellular ligand-gated ion channel activity);Butalbital (Inhibitory extracellular ligand-gated ion channel activity);Topiramate (Inhibitory extracellular ligand-gated ion channel activity);Topiramate (Inhibitory extracellular ligand-gated ion channel activity);Etomidate (Inhibitory extracellular ligand-gated ion channel activity);Etomidate (Inhibitory extracellular ligand-gated ion channel activity);Talbutal (Inhibitory extracellular ligand-gated ion channel activity);Talbutal (Inhibitory extracellular ligand-gated ion channel activity);Pentobarbital (Inhibitory extracellular ligand-gated ion channel activity);Pentobarbital (Inhibitory extracellular ligand-gated ion channel activity);Olanzapine (Inhibitory extracellular ligand-gated ion channel activity);Clobazam (Inhibitory extracellular ligand-gated ion channel activity);Meprobamate (Inhibitory extracellular ligand-gated ion channel activity);Meprobamate (Inhibitory extracellular ligand-gated ion channel activity);Eszopiclone (Inhibitory extracellular ligand-gated ion channel activity);Eszopiclone (Inhibitory extracellular ligand-gated ion channel activity);Alprazolam (Inhibitory extracellular ligand-gated ion channel activity);Secobarbital (Inhibitory extracellular ligand-gated ion channel activity);Zolpidem (Inhibitory extracellular ligand-gated ion channel activity);Metharbital (Inhibitory extracellular ligand-gated ion channel activity);Metharbital (Inhibitory extracellular ligand-gated ion channel activity);Picrotoxin (Inhibitory extracellular ligand-gated ion channel activity);Methohexital (Inhibitory extracellular ligand-gated ion channel activity);Chlordiazepoxide (Inhibitory extracellular ligand-gated ion channel activity);Amoxapine (Inhibitory extracellular ligand-gated ion channel activity);Amoxapine (Inhibitory extracellular ligand-gated ion channel activity);Adinazolam (Inhibitory extracellular ligand-gated ion channel activity);Thiopental (Inhibitory extracellular ligand-gated ion channel activity);Clorazepate (Inhibitory extracellular ligand-gated ion channel activity);Acamprosate (Inhibitory extracellular ligand-gated ion channel activity);Midazolam (Inhibitory extracellular ligand-gated ion channel activity);Flurazepam (Inhibitory extracellular ligand-gated ion channel activity);Isoflurane (Inhibitory extracellular ligand-gated ion channel activity);Isoflurane (Inhibitory extracellular ligand-gated ion channel activity);Primidone (Inhibitory extracellular ligand-gated ion channel activity);Primidone (Inhibitory extracellular ligand-gated ion channel activity);Halazepam (Inhibitory extracellular ligand-gated ion channel activity);Halazepam (Inhibitory extracellular ligand-gated ion channel activity);Propofol (Inhibitory extracellular ligand-gated ion channel activity);Diazepam (Inhibitory extracellular ligand-gated ion channel activity);Diazepam (Inhibitory extracellular ligand-gated ion channel activity);Progabide (Inhibitory extracellular ligand-gated ion channel activity);Oxazepam (Inhibitory extracellular ligand-gated ion channel activity);Oxazepam (Inhibitory extracellular ligand-gated ion channel activity);Methylphenobarbital (Inhibitory extracellular ligand-gated ion channel activity);Triazolam (Inhibitory extracellular ligand-gated ion channel activity);Triazolam (Inhibitory extracellular ligand-gated ion channel activity);Ethanol (Inhibitory extracellular ligand-gated ion channel activity);Zaleplon (Inhibitory extracellular ligand-gated ion channel activity);Methoxyflurane (Inhibitory extracellular ligand-gated ion channel activity);Methoxyflurane (Inhibitory extracellular ligand-gated ion channel activity);Ergoloid mesylate (Inhibitory extracellular ligand-gated ion channel activity);Clonazepam (Inhibitory extracellular ligand-gated ion channel activity);Methyprylon (Inhibitory extracellular ligand-gated ion channel activity);Methyprylon (Inhibitory extracellular ligand-gated ion channel activity);Thiamylal (Inhibitory extracellular ligand-gated ion channel activity);Halothane (Inhibitory extracellular ligand-gated ion channel activity);Halothane (Inhibitory extracellular ligand-gated ion channel activity);Phenobarbital (Inhibitory extracellular ligand-gated ion channel activity);Desflurane (Inhibitory extracellular ligand-gated ion channel activity);Zopiclone (Inhibitory extracellular ligand-gated ion channel activity);Flumazenil (Inhibitory extracellular ligand-gated ion channel activity);Flumazenil (Inhibitory extracellular ligand-gated ion channel activity);Estazolam (Inhibitory extracellular ligand-gated ion channel activity);Estazolam (Inhibitory extracellular ligand-gated ion channel activity);Sevoflurane (Inhibitory extracellular ligand-gated ion channel activity);Sevoflurane (Inhibitory extracellular ligand-gated ion channel activity);Dihydroquinidine barbiturate (Inhibitory extracellular ligand-gated ion channel activity);Quinidine barbiturate (Inhibitory extracellular ligand-gated ion channel activity);Amobarbital (Inhibitory extracellular ligand-gated ion channel activity);Aprobarbital (Inhibitory extracellular ligand-gated ion channel activity);Butethal (Inhibitory extracellular ligand-gated ion channel activity);Heptabarbital (Inhibitory extracellular ligand-gated ion channel activity);Hexobarbital (Inhibitory extracellular ligand-gated ion channel activity);Ginkgo biloba (Inhibitory extracellular ligand-gated ion channel activity);Glutethimide (Inhibitory extracellular ligand-gated ion channel activity);Glutethimide (Inhibitory extracellular ligand-gated ion channel activity);Barbital (Inhibitory extracellular ligand-gated ion channel activity);Barbituric acid derivative (Inhibitory extracellular ligand-gated ion channel activity);Bromazepam (Inhibitory extracellular ligand-gated ion channel activity);Clotiazepam (Inhibitory extracellular ligand-gated ion channel activity);Fludiazepam (Inhibitory extracellular ligand-gated ion channel activity);Ketazolam (Inhibitory extracellular ligand-gated ion channel activity);Prazepam (Inhibitory extracellular ligand-gated ion channel activity);Prazepam (Inhibitory extracellular ligand-gated ion channel activity);Quazepam (Inhibitory extracellular ligand-gated ion channel activity);Quazepam (Inhibitory extracellular ligand-gated ion channel activity);Cinolazepam (Inhibitory extracellular ligand-gated ion channel activity);Nitrazepam (Inhibitory extracellular ligand-gated ion channel activity);Prasterone (Inhibitory extracellular ligand-gated ion channel activity);Ganaxolone (Inhibitory extracellular ligand-gated ion channel activity);Thiocolchicoside (Inhibitory extracellular ligand-gated ion channel activity)


針對該基因所產(chǎn)生的突變,可能有正確效果的藥物(中文版):

勞拉西泮(抑制細(xì)胞外配體門控離子通道活性);乙氯維諾(抑制細(xì)胞外配體門控離子通道活性);恩氟烷(抑制細(xì)胞外配體門控離子通道活性);替馬西泮(抑制細(xì)胞外配體門控離子通道活性);替馬西泮( Inhibitory extracellular ligand-gated ion channel activity);Butabarbital(抑制胞外配體門控離子通道活性);Butalbital(抑制胞外配體門控離子通道活性);Butalbital(抑制胞外配體門控離子通道活性);托吡酯(抑制胞外配體門離子通道活性)配體門控離子通道活性);托吡酯(抑制性細(xì)胞外配體門控離子通道活性);依托咪酯(抑制性細(xì)胞外配體門控離子通道活性);依托咪酯(抑制性細(xì)胞外配體門控離子通道活性);他布妥(抑制性細(xì)胞外配體-門控離子通道活性)門離子通道活性);他布妥(抑制細(xì)胞外配體門離子通道活性);戊巴比妥(抑制細(xì)胞外配體門離子通道活性);戊巴比妥(抑制細(xì)胞外配體門離子通道活性);奧氮平(抑制細(xì)胞外配體門離子通道活性)通道活性);氯巴占(抑制細(xì)胞外配體門控離子通道活性);甲丙氨酯(抑制細(xì)胞外配體門控離子通道活性);甲丙氨酯(抑制細(xì)胞外配體門控離子通道活性);依佐匹克?。ㄒ种萍?xì)胞外配體門控離子通道活性);右佐匹克?。ㄒ种萍?xì)胞外配體門控離子通道活性);阿普唑侖(抑制細(xì)胞外配體門控離子通道活性);司可巴比妥(抑制細(xì)胞外配體門控離子通道活性);唑吡坦(抑制細(xì)胞外配體門控離子通道活性); Metharbital(抑制細(xì)胞外配體門控離子通道活性);Metharbital(抑制細(xì)胞外配體門控離子通道活性);Picrotoxin(抑制細(xì)胞外配體門控離子通道活性);Methohexital(抑制細(xì)胞外配體門控離子通道活性);氯氮卓( Inhibitory extracellular ligand-gated ion channel activity);Amoxapine(抑制細(xì)胞外配體門控離子通道活性);Amoxapine(抑制細(xì)胞外配體門控離子通道活性);Adinazolam(抑制細(xì)胞外配體門控離子通道活性);Thioopental(抑制細(xì)胞外配體門控離子通道活性)配體門控離子通道活性);氯拉西泮(抑制細(xì)胞外配體門控離子通道活性);阿坎酸(抑制細(xì)胞外配體門控離子通道活性);咪達(dá)唑侖(抑制細(xì)胞外配體門控離子通道活性);氟拉西泮(抑制細(xì)胞外配體-門控離子通道活性) gated ion channel activity);Isoflurane (Inhibitory extracellular ligand-gated ion channel activity);Isoflurane (Inhibitory extracellular ligand-gated ion channel activity);撲米酮(Inhibitory extracellular ligand-gated ion channel activity);撲米酮(Inhibitory extracellular ligand-gated ion activity)通道活性);哈拉西泮(抑制細(xì)胞外配體門控離子通道活性);哈拉西泮(抑制細(xì)胞外配體門控離子通道活性);異丙酚(抑制細(xì)胞外配體門控離子通道活性);地西泮(抑制細(xì)胞外配體門控離子通道活性);地西泮(抑制細(xì)胞外配體門控離子通道活性);Progabide(抑制細(xì)胞外配體門控離子通道活性);奧沙西泮(抑制細(xì)胞外配體門控離子通道活性);奧沙西泮(抑制細(xì)胞外配體門控離子通道活性);甲基苯巴比妥(抑制細(xì)胞外配體門控離子通道活性);三唑侖(抑制細(xì)胞外配體門控離子通道活性);三唑侖(抑制細(xì)胞外配體門控離子通道活性);乙醇(抑制細(xì)胞外配體門控離子通道活性);扎來普隆( Inhibitory extracellular ligand-gated ion channel activity);Methoxyflurane(抑制細(xì)胞外配體門控離子通道活性);Methoxyflurane(抑制細(xì)胞外配體門控離子通道活性);Ergoloid mesylate(抑制細(xì)胞外配體門控離子通道活性);Clonazepam(抑制細(xì)胞外配體門控離子通道活性);Methyprylon(抑制性細(xì)胞外配體門控離子通道活性);Methyprylon(抑制性細(xì)胞外配體門控離子通道活性);Thiamylal(抑制性細(xì)胞外配體門控離子通道活性);Halothane(抑制性細(xì)胞外配體-門控離子通道活性);氟烷(抑制性細(xì)胞外配體門控離子通道活性);苯巴比妥(抑制性細(xì)胞外配體門控離子通道活性);地氟烷(抑制性細(xì)胞外配體門控離子通道活性);佐匹克?。ㄒ种菩约?xì)胞外配體門控離子通道活性)離子通道活性);氟馬西尼(抑制細(xì)胞外配體門控離子通道活性);氟馬西尼(抑制細(xì)胞外配體門控離子通道活性);艾司唑侖(抑制細(xì)胞外配體門控離子通道活性);艾司唑侖(抑制細(xì)胞外配體門控離子通道活性);七氟醚(抑制細(xì)胞外配體門控離子通道活性);七氟醚(抑制細(xì)胞外配體門控離子通道活性);二氫奎尼丁巴比妥酸鹽(抑制細(xì)胞外配體門控離子通道活性);奎尼丁巴比妥酸鹽(抑制細(xì)胞外配體門控離子通道Aprobarbital(抑制細(xì)胞外配體門控離子通道活性);Aprobarbital(抑制細(xì)胞外配體門控離子通道活性);Butethal(抑制細(xì)胞外配體門控離子通道活性);Heptabarbital(抑制細(xì)胞外配體門控離子通道活性) ;己巴比妥(抑制細(xì)胞外配體門控離子通道活性);銀杏葉(抑制細(xì)胞外配體門控離子通道活性);谷氨酰胺(抑制細(xì)胞外配體門控離子通道活性);谷氨酰胺(抑制細(xì)胞外配體門控離子通道活性);巴比妥(抑制細(xì)胞外配體門控離子通道活性);巴比妥酸衍生物(抑制細(xì)胞外配體門控離子通道活性);溴西泮(抑制細(xì)胞外配體門控離子通道活性);克洛硫西泮(抑制細(xì)胞外配體門控離子通道活性);氟地西泮(抑制細(xì)胞外配體門控離子通道活性);酮唑侖(抑制細(xì)胞外配體門控離子通道活性);普拉西泮(抑制細(xì)胞外配體門控離子通道活性);普拉西泮(抑制細(xì)胞外配體門控離子通道活性);喹西泮(抑制細(xì)胞外配體門控離子通道活性);Quazepam(抑制細(xì)胞外配體門控離子通道活性);Cinolazepam(抑制細(xì)胞外配體門控離子通道活性);Nitrazepam(抑制細(xì)胞外配體門控離子通道活性);Prasterone(抑制細(xì)胞外配體門控離子通道活性)配體門控離子通道活性);加奈索酮(抑制細(xì)胞外配體門控離子通道活性);硫秋水仙苷(抑制細(xì)胞外配體門控離子通道活性)

GABRA1疾病風(fēng)險評估的作用

(責(zé)任編輯:佳學(xué)基因)
頂一下
(0)
0%
踩一下
(0)
0%
推薦內(nèi)容:
來了,就說兩句!
請自覺遵守互聯(lián)網(wǎng)相關(guān)的政策法規(guī),嚴(yán)禁發(fā)布色情、暴力、反動的言論。
評價:
表情:
用戶名: 驗證碼: 點擊我更換圖片

Copyright © 2013-2033 網(wǎng)站由佳學(xué)基因醫(yī)學(xué)技術(shù)(北京)有限公司,湖北佳學(xué)基因醫(yī)學(xué)檢驗實驗室有限公司所有 京ICP備16057506號-1;鄂ICP備2021017120號-1

設(shè)計制作 基因解碼基因檢測信息技術(shù)部